Product Information
JOYEAUX-28 TABLET is a generic product labeled by Xiromed LLC, priced at $3.4454 per EA under NDC 70700017785. Its NADAC has been published 146 times since Dec 20, 2023.
FDA first approved this application on Aug 16, 2023. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Xiromed LLCNDC
70700017785
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA214640FDA Approved
8/16/2023
TE Code
AB3
On Market Since
8/17/2023
Price Statistics
The NADAC for JOYEAUX-28 TABLET has been published 146 times since Dec 20, 2023, and over the history we have for it it has declined 58.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4454 per EA |
|---|---|
| All-time high | $8.2737 (Apr 10, 2024) |
| All-time low | $3.4240 (Jul 22, 2026) |
| 52-week high | $5.2252 |
| 52-week low | $3.4240 |
| Median price | $5.3487 |
| Average price | $5.5356 |
| Largest weekly change | -15.2% (May 22, 2024) |
| Weeks tracked | 146 |
| Tracking since | Dec 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Levonorgestrel and Ethinyl Estradiol and Ferrous Fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel and Ethinyl Estradiol and Ferrous Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of JOYEAUX-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for JOYEAUX-28 TABLET, manufactured by Xiromed LLC, is $3.4454 per EA (NDC 70700017785), effective Sep 30, 2026.
How has the price of JOYEAUX-28 TABLET changed over time?
Over the history we have for it, the NADAC for JOYEAUX-28 TABLET has declined 58.4%. It has been tracked across 146 weekly CMS publications since Dec 20, 2023.
What are the highest and lowest recorded NADAC prices for JOYEAUX-28 TABLET?
Since Dec 20, 2023, the NADAC for JOYEAUX-28 TABLET has ranged from a low of $3.4240 (Jul 22, 2026) to a high of $8.2737 (Apr 10, 2024), with a median of $5.3487 per EA.
Are there cheaper alternatives to JOYEAUX-28 TABLET?
No other NADAC-published product currently shares the active ingredient and strength of JOYEAUX-28 TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures JOYEAUX-28 TABLET?
JOYEAUX-28 TABLET (NDC 70700017785) is labeled by Xiromed LLC, and CMS classifies it as a generic product.